ClinicalTrials.Veeva

Menu

Gingivitis Treated With Chlorhexidine 0.12% Mouthwash in Young Adults

U

Universidade Federal Fluminense

Status

Completed

Conditions

Age Problem

Treatments

Procedure: 0.12% chlorhexidine

Study type

Interventional

Funder types

Other

Identifiers

NCT04658225
CAAE: 69912817.0.0000.5626.

Details and patient eligibility

About

The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.

Full description

Thirty patients with gingivitis ages 18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will be selected and evaluate at baseline and after 4 weeks.

Enrollment

30 patients

Sex

All

Ages

30 to 30 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of gingivitis
  • Probing depth (PD) with maximum 3 mm
  • Minimum of 20 teeth
  • Age between 18 and 30 years old

Exclusion criteria

  • Patients with periodontal disease (PD ≥ 4mm with clinical attachment loss)
  • Diabetes
  • Osteoporosis
  • Pregnant or lactating females
  • Smokers
  • Users of immune suppressive medication
  • Phenytoin or cyclosporine
  • Calcium channel blockers
  • Antibiotics
  • Nonsteroidal anti-inflammatory drugs
  • HIV+ or AIDS

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups, including a placebo group

Solution 1
Active Comparator group
Description:
0.12% chlorhexidine
Treatment:
Procedure: 0.12% chlorhexidine
Solution 2
Placebo Comparator group
Description:
Saline solution
Treatment:
Procedure: 0.12% chlorhexidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems